Patent Application
Utility
App. No. 16/575,769
· Confirmation No. 9825
METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS)
Applicant:
Salix Pharmaceuticals, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-11-08 | ABN |
Abandonment | 2 | View | |
| 2021-04-27 | CTNF |
Non-Final Rejection | 7 | View | |
| 2021-04-27 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2021-04-27 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2021-04-27 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2021-04-27 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2021-04-27 | 1449 |
List of References cited by applicant and considered by examiner | 9 | View | |
| 2021-04-27 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-12-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-12-02 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-12-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-12-02 | FOR |
Foreign Reference | 130 | View | |
| 2020-12-02 | FOR |
Foreign Reference | 32 | View | |
| 2020-04-23 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2020-03-17 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-03-17 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-03-17 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-03-17 | FOR |
Foreign Reference | 30 | View | |
| 2020-03-17 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 9 | View | |
| 2020-01-23 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2020-01-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-01-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2020-01-14 | PA.. |
Power of Attorney | 1 | View | |
| 2020-01-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-01-09 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2020-01-09 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-01-09 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-01-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-01-09 | REM |
Applicant Arguments/Remarks Made in an Amendment | 66 | View | |
| 2020-01-09 | SPEC |
Specification | 66 | View | |
| 2020-01-09 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-01-09 | A.PE |
Preliminary Amendment | 1 | View | |
| 2020-01-09 | SPEC |
Specification | 1 | View | |
| 2020-01-09 | CLM |
Claims | 3 | View | |
| 2020-01-09 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2019-10-03 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-10-03 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-10-03 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2019-10-03 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2019-09-19 | TRNA |
Transmittal of New Application | 1 | View | |
| 2019-09-19 | DRW |
Drawings-only black and white line drawings | 13 | View | |
| 2019-09-19 | OATH |
Oath or Declaration filed | 2 | View | |
| 2019-09-19 | ADS |
Application Data Sheet | 9 | View | |
| 2019-09-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-09-19 | SPEC |
Specification | 66 | View | |
| 2019-09-19 | CLM |
Claims | 4 | View | |
| 2019-09-19 | ABST |
Abstract | 1 | View |
Inventors
William Forbes
Raleigh, NC
Enoch Bortey
Chapel Hill, NC
Attorneys & Agents of Record
Classification
USPC
514/279
A61K31/437
A61P1/06
A61P43/00
A61P1/10
A61P29/02
A61P1/12
A61P31/04
A61P1/00
A61P1/04
A61K9/0053
A61K9/14
A61K9/20
A61K9/48
C07D491/22
C07D498/22
Prosecution
- Examiner
- SCHMITT, MICHAEL J
- Art Unit
- 1629
- Customer No.
- 75093
- Docket No.
- 119557-04010
- Confirmation No.
- 9825
Publication
- Pub. No.
- US20200121653A1
- Pub. Date
- 2020-04-23
Parent
is a Continuation of
→
App. 15/902,179
· US 10,456,384
Filed 2018-02-22
· Patented Case
Parent
is a Continuation of
→
App. 15/398,283
· US 9,931,325
Filed 2017-01-04
· Patented Case
Parent
is a Continuation of
→
App. 13/755,578
· US 9,566,270
Filed 2013-01-31
· Patented Case
Parent
is a Continuation of
→
App. 12/880,739
Filed 2010-09-13
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 61/329,511
Filed 2010-04-29
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/262,475
Filed 2009-11-18
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/241,945
Filed 2009-09-13
· Provisional Application Expired
Parent
is a Continuation in-part of
→
App. 12/393,979
· US 8,309,569
Filed 2009-02-26
· Patented Case
Parent
Claims priority from a provisional application
→
App. 61/102,801
Filed 2008-10-03
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/031,679
Filed 2008-02-26
· Provisional Application Expired
Child
is a Continuation of
→
App. 16/738,392
· US 10,765,667
Filed 2020-01-09
· Patented Case
Child
is a Continuation of
→
App. 16/944,956
Filed 2020-07-31
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/892,982
· US 11,564,912
Filed 2022-08-22
· Patented Case
Child
is a Continuation of
→
App. 18/628,366
Filed 2024-04-05
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 17/197,561
· US 11,779,571
Filed 2021-03-10
· Patented Case
Child
is a Continuation of
→
App. 18/241,355
Filed 2023-09-01
· Response to Non-Final Office Action Entered and Forwarded to Examiner
Child
is a Continuation of
→
App. 18/628,353
Filed 2024-04-05
· Abandoned -- Failure to Respond to an Office Action
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH US, LLC,
SOLTA MEDICAL, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH AMERICAS, INC.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT
Recorded 2022-02-10
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2021-06-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH US, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2020-02-04
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH US, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2020-02-04
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-01-14
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-01-14
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/575,769
- Filed
- 2019-09-19
- Pub. No.
- US20200121653A1
- Examiner
- SCHMITT, MICHAEL J
- Art Unit
- 1629
External Links